Emily Leproust is the founder of Twist Bioscience. Twist Bioscience has raised $82M in total funding. Latest round: Series C.
Emily Leproust is the chief executive officer of Twist Bioscience, a company focused on synthetic DNA. Twist Bioscience has developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform. Since its founding in 2013, the company has raised a total of $82.1 million as of June 2015, with investors including Illumina, Fidelity Management, and ARCH Venture Partners.
Full founder directory · Investor directory · Company funding database · Fundraising library